To determine whether altered splicing of CEACAM1 is linked to tumorigenesis, we examined the splicing profile of CEACAM1 transcripts in a variety of human cancer cell lines derived from brain, breast, colon and prostate. The gene discussed is CEACAM1; the disease is cancer.